Related Experiment Video
Updated: Dec 16, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
Deep Docking: A Deep Learning Platform for Augmentation of Structure Based Drug Discovery
Francesco Gentile1, Vibudh Agrawal1, Michael Hsing1
1Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia V6H3Z6, Canada.
Deep Docking (DD) accelerates drug discovery by rapidly screening billions of molecules using deep learning. This novel platform significantly reduces data and enriches high-scoring compounds for faster identification of potential drug candidates.
Area of Science:
- Computational chemistry
- cheminformatics
- Artificial intelligence in drug discovery
Background:
- Drug discovery is a lengthy and expensive process, often taking decades and billions of dollars.
- Virtual screening methods like molecular docking accelerate drug discovery but struggle with massive chemical databases exceeding billions of records.
- The rapid expansion of chemical libraries presents opportunities but necessitates faster screening protocols.
Purpose of the Study:
- To introduce Deep Docking (DD), a novel deep learning platform for rapid and accurate docking of billions of molecular structures.
- To address the challenge of screening vast chemical libraries in drug discovery.
- To provide a computationally efficient method for identifying potential drug candidates.
Main Methods:
- Developed Deep Docking (DD), a deep learning platform utilizing quantitative structure-activity relationship (QSAR) deep models.
- Trained QSAR models on docking scores from subsets of chemical libraries to predict outcomes for unprocessed entries.
- Iteratively removed unfavorable molecules to approximate docking outcomes.
- Integrated DD with the FRED docking program for screening.
Main Results:
- Successfully screened 1.36 billion molecules from the ZINC15 library against 12 target proteins.
- Achieved up to 100-fold data reduction and 6000-fold enrichment of high-scoring molecules.
- Demonstrated rapid and accurate calculation of docking scores without significant loss of favorable entities.
- Validated the DD methodology's effectiveness in large-scale virtual screening.
Conclusions:
- Deep Docking (DD) offers a significant advancement in accelerating drug discovery by enabling rapid screening of massive chemical libraries.
- The DD platform provides an efficient and accurate method for identifying promising drug candidates from billions of molecules.
- The DD protocol is versatile, compatible with any docking program, and has been made publicly available for broader research use.
More Related Videos
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
05:08Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
Published on: July 8, 2025
Related Concept Videos
Drug Discovery: Overview
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...